当前位置：
X-MOL 学术
›
Nano-Micro Lett.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Artificial Nanoscale Erythrocytes from Clinically Relevant Compounds for Enhancing Cancer Immunotherapy
Nano-Micro Letters ( IF 26.6 ) Pub Date : 2020-04-13 , DOI: 10.1007/s40820-020-00428-y Wenquan Ou 1 , Kang Sik Nam 2 , Dae Hoon Park 2 , Jungho Hwang 2 , Sae Kwang Ku 3 , Chul Soon Yong 1 , Jong Oh Kim 1 , Jeong Hoon Byeon 4
中文翻译：
来自临床相关化合物的人工纳米级红细胞增强癌症免疫治疗
更新日期：2020-04-22
Nano-Micro Letters ( IF 26.6 ) Pub Date : 2020-04-13 , DOI: 10.1007/s40820-020-00428-y Wenquan Ou 1 , Kang Sik Nam 2 , Dae Hoon Park 2 , Jungho Hwang 2 , Sae Kwang Ku 3 , Chul Soon Yong 1 , Jong Oh Kim 1 , Jeong Hoon Byeon 4
Affiliation
-
A two-phase coaxial electrospray was designed to produce paclitaxel-loaded fake blood cell Eudragit particles (Eu-FBCP/PTX).
-
The chemo-immunotherapeutic efficacy was further enhanced after combining with anti-programmed death-ligand 1 antibodies (Eu-FBCP/PTX + aPL).
中文翻译：
来自临床相关化合物的人工纳米级红细胞增强癌症免疫治疗
-
设计了两相同轴电喷雾以产生载有紫杉醇的假血细胞Eudragit颗粒（Eu-FBCP / PTX）。
-
与抗编程的死亡配体1抗体（Eu-FBCP / PTX + aPL）结合后，化学免疫疗法的疗效进一步增强。
京公网安备 11010802027423号